FKBP5 and psychiatric disorder: In parallel, as discussed in Section 6, advancements in chemical and drug design are finally able to pharmacologically target FKBP51 with relatively good precision, with promising opportunities for the treatment of stress-related mental disorders and possibly other diseases.